Waters Stock (NYSE:WAT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$299.63

52W Range

$275.05 - $414.15

50D Avg

$357.63

200D Avg

$341.52

Market Cap

$17.71B

Avg Vol (3M)

$990.21K

Beta

1.20

Div Yield

-

WAT Company Profile


Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

7,600

IPO Date

Nov 17, 1995

Website

WAT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Ta Instrument Systems$243.82M$246.20M$252.88M
Waters Service$1.08B$1.01B$951.42M
Waters Instrument Systems$1.10B$1.03B$1.11B
Ta Service$108.02M$107.76M$101.95M
Chemistry Consumables$631.46M$565.48M$541.47M
Service--$1.05B
Product--$1.90B

Fiscal year ends in Dec 25 | Currency in USD

WAT Financial Summary


Dec 25Dec 24Dec 23
Revenue$3.17B$2.96B$2.96B
Operating Income$893.22M$826.35M$817.68M
Net Income$642.63M$637.83M$642.23M
EBITDA$1.10B$1.04B$1.00B
Basic EPS$10.80$10.75$10.87
Diluted EPS$10.76$10.71$10.84

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Feb 09, 26 | 8:30 AM
Q3 25Nov 04, 25 | 8:00 AM
Q2 25Aug 04, 25 | 8:00 AM

Peer Comparison


TickerCompany
MEDPMedpace Holdings, Inc.
MTDMettler-Toledo International Inc.
ZBHZimmer Biomet Holdings, Inc.
INCYIncyte Corporation
WSTWest Pharmaceutical Services, Inc.
DGXQuest Diagnostics Incorporated
LHLabcorp Holdings Inc.
STESTERIS plc
ILMNIllumina, Inc.
DXCMDexCom, Inc.